News about Global Pharma

Alembic Pharmaceuticals Gets USFDA Final Approval for Divalproex Sodium Delayed-Release Capsules USP, 125 mg

The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Depakote Sprinkle Capsules, 125 mg, of AbbVie Inc.

Global Pharma | 20/12/2024 | By Manvi |  259

Novo Holdings Completes Acquisition of Catalent

With the completion of the transaction, holders of Catalent common stock are entitled to receive USD 63.50 per share in cash, representing a premium of approximately 47.5 percent to the 60-day volume-weighted average price as of February 2, 2024.

Global Pharma | 20/12/2024 | By Aishwarya |  389

Merck Signs Exclusive Global License Deal with Hansoh Pharma for Oral GLP-1 Receptor Agonist

Under the agreement, Hansoh Pharma has granted Merck an exclusive global license to develop, manufacture and commercialize HS-10535.

Global Pharma | 19/12/2024 | By Aishwarya |  574

MTPA Signs Deal with Dewpoint to Advance Small Molecule Condensate Modulator

The collaboration focuses on developing a novel TDP-43 small molecule condensate modulator (c-mod) for amyotrophic lateral sclerosis (ALS), furthering MTPC's commitment to advancing innovation in ALS and central nervous system (CNS) diseases.

Global Pharma | 19/12/2024 | By Aishwarya |  380

Noema Pharma Closes its Series B Financing Round with USD 147 Million Capital Funding

The new financing will support Noema Pharma’s four active Phase 2 trials, with key data readouts anticipated in 2025.

Global Pharma | 18/12/2024 | By Aishwarya |  728

Lilly and EVA Pharma Secure Approval to Distribute Locally Manufactured Insulin in Egypt

Under this agreement, Lilly has been supplying its active pharmaceutical ingredient (API) for insulin to EVA Pharma at a significantly reduced price and providing pro-bono technology transfer to enable EVA Pharma to formulate, fill and finish insulin vials and cartridges.

Global Pharma | 18/12/2024 | By Aishwarya |  972

AbbVie to Acquire Nimble Therapeutics to Expand its Immunology Pipeline

AbbVie will acquire Nimble's peptide synthesis, screening, and optimization platform, which uses proprietary technology to help drive rapid discovery and optimization of peptide candidates for a range of targets.

Global Pharma | 18/12/2024 | By Aishwarya |  841

ENEA-Tech Invests EUR 6 Million in BetaGlue Therapeutics

This EUR 6 million investment from ENEA-Tech follows the EUR 8 million equity financing round and the EUR 10 million EIC Accelerator Award announced in June of this year.

Global Pharma | 17/12/2024 | By Aishwarya |  370

VectorY Welcomes Jim Scibetta as New CEO

Scibetta brings more than 20 years of executive leadership experience, having built earlier stage companies focused on developing novel therapeutics for high unmet medical needs into mature biotechnology companies.

Global Pharma | 17/12/2024 | By Aishwarya |  458

CPHI Milan Records 59,000 Visitors from Pharma Industry

The event’s success is widely used as a proxy for overall growth in global pharma in the year ahead, with attendance up 9 percent on 2023 and a remarkable 45 percent over the last two years.

Global Pharma | 17/12/2024 | By Aishwarya |  618